Severe iron deficiency anemia in the paediatric emergency department: A retrospective study.
Anemia
Emergency medicine
Iron deficiency
Paediatrics
Journal
Paediatrics & child health
ISSN: 1205-7088
Titre abrégé: Paediatr Child Health
Pays: England
ID NLM: 9815960
Informations de publication
Date de publication:
Feb 2023
Feb 2023
Historique:
received:
18
06
2022
accepted:
18
08
2022
entrez:
3
3
2023
pubmed:
4
3
2023
medline:
4
3
2023
Statut:
epublish
Résumé
Transfusion is discouraged in hemodynamically stable children with severe iron deficiency anemia (IDA). Intravenous (IV) iron sucrose (IS) could be an alternative for some patients; however, there is a paucity of data on its use in the paediatric emergency department (ED). We analyzed patients presenting with severe IDA at the Children's Hospital of Eastern Ontario (CHEO) ED between September 1, 2017, and June 1, 2021. We defined severe IDA as microcytic anemia <70 g/L and either a ferritin <12 ng/mL or a documented clinical diagnosis. Of 57 patients, 34 (59%) presented with nutritional IDA and 16 (28%) presented with IDA secondary to menstrual bleeding. Fifty-five (95%) patients received oral iron. Thirteen (23%) patients additionally received IS and after 2 weeks, the average Hgb was similar to transfused patients. The median time for patients receiving IS without PRBC transfusion to increase their Hgb by at least 20 g/L was 7 days (95%CI 0.7 to 10.5 days). Of 16 (28%) children who were transfused with PRBC, there were three mild reactions, and one patient who developed transfusion associated circulatory overload (TACO). There were two mild and no severe reactions to IV iron. There were no return visits to the ED due to anemia in the following 30 days. Management of severe IDA with IS was associated with a rapid rise in Hgb without severe reactions or returns to ED. This study highlights a strategy for management of severe IDA in hemodynamically stable children that spares them the risks associated with PRBC transfusion. Paediatric specific guidelines and prospective studies are needed to guide the use of IV iron in this population.
Sections du résumé
Background
UNASSIGNED
Transfusion is discouraged in hemodynamically stable children with severe iron deficiency anemia (IDA). Intravenous (IV) iron sucrose (IS) could be an alternative for some patients; however, there is a paucity of data on its use in the paediatric emergency department (ED).
Methods
UNASSIGNED
We analyzed patients presenting with severe IDA at the Children's Hospital of Eastern Ontario (CHEO) ED between September 1, 2017, and June 1, 2021. We defined severe IDA as microcytic anemia <70 g/L and either a ferritin <12 ng/mL or a documented clinical diagnosis.
Results
UNASSIGNED
Of 57 patients, 34 (59%) presented with nutritional IDA and 16 (28%) presented with IDA secondary to menstrual bleeding. Fifty-five (95%) patients received oral iron. Thirteen (23%) patients additionally received IS and after 2 weeks, the average Hgb was similar to transfused patients. The median time for patients receiving IS without PRBC transfusion to increase their Hgb by at least 20 g/L was 7 days (95%CI 0.7 to 10.5 days). Of 16 (28%) children who were transfused with PRBC, there were three mild reactions, and one patient who developed transfusion associated circulatory overload (TACO). There were two mild and no severe reactions to IV iron. There were no return visits to the ED due to anemia in the following 30 days.
Conclusions
UNASSIGNED
Management of severe IDA with IS was associated with a rapid rise in Hgb without severe reactions or returns to ED. This study highlights a strategy for management of severe IDA in hemodynamically stable children that spares them the risks associated with PRBC transfusion. Paediatric specific guidelines and prospective studies are needed to guide the use of IV iron in this population.
Identifiants
pubmed: 36865758
doi: 10.1093/pch/pxac095
pii: pxac095
pmc: PMC9971582
doi:
Types de publication
Journal Article
Langues
eng
Pagination
30-36Informations de copyright
© The Author(s) 2022. Published by Oxford University Press on behalf of the Canadian Paediatric Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Références
Pediatr Blood Cancer. 2013 Nov;60(11):1747-52
pubmed: 23832487
Pediatr Hematol Oncol. 2005 Jan-Feb;22(1):77-81
pubmed: 15770835
World J Pediatr. 2016 Feb;12(1):109-13
pubmed: 25754747
Can J Public Health. 2020 Oct;111(5):682-693
pubmed: 32170646
Am J Med. 1993 Feb;94(2):120-4
pubmed: 8430708
J Pediatr Hematol Oncol. 2017 Jul;39(5):e259-e262
pubmed: 28562517
Acta Paediatr. 2005 Dec;94(12):1738-41
pubmed: 16431410
Isr Med Assoc J. 2008 May;10(5):335-8
pubmed: 18605353
Pediatr Blood Cancer. 2021 Aug;68(8):e28967
pubmed: 34047047
Nephrol Dial Transplant. 2006 Feb;21(2):378-82
pubmed: 16286429
Crit Care Med. 2017 Jun;45(6):1061-1093
pubmed: 28509730
Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):57-66
pubmed: 27913463
Food Nutr Bull. 2003 Dec;24(4 Suppl):S99-103
pubmed: 17016951
BMC Gastroenterol. 2014 Oct 17;14:184
pubmed: 25326048
JAMA. 2017 Jun 13;317(22):2297-2304
pubmed: 28609534
Clin Pediatr (Phila). 2009 Nov;48(9):902-3
pubmed: 19483131
J Pediatr. 1997 Oct;131(4):575-81
pubmed: 9386662
J Pediatr Pharmacol Ther. 2016 Mar-Apr;21(2):162-8
pubmed: 27199624
Arch Dis Child. 2004 Oct;89(10):950-5
pubmed: 15383440
Mayo Clin Proc. 2015 Jan;90(1):12-23
pubmed: 25572192
J Pediatr Gastroenterol Nutr. 2002 Mar;34(3):286-90
pubmed: 11964953
Transfusion. 2018 Aug;58(8):1902-1908
pubmed: 29664169
Eur J Pediatr. 2017 Oct;176(10):1419-1423
pubmed: 28844092
Eur J Pediatr. 2020 Apr;179(4):527-545
pubmed: 32020331
Glob Pediatr Health. 2016 Jan 22;3:2333794X15623244
pubmed: 27335995
J Pediatr. 2017 Jan;180:212-216
pubmed: 27776750
Transl Pediatr. 2019 Jan;8(1):28-34
pubmed: 30881896
JAMA. 2016 Nov 15;316(19):2025-2035
pubmed: 27732721
Pediatr Blood Cancer. 2011 Apr;56(4):615-9
pubmed: 21298748
Pediatr Blood Cancer. 2018 Jun;65(6):e26995
pubmed: 29369486
Pediatr Blood Cancer. 2021 Jul;68(7):e29024
pubmed: 33769677
Pediatr Blood Cancer. 2020 Oct;67(10):e28614
pubmed: 32729200
Am J Hematol. 2021 Jun 1;96(6):E215-E218
pubmed: 33735470
BMJ. 2013 Aug 15;347:f4822
pubmed: 23950195
Stat Med. 1992 Sep 15;11(12):1569-78
pubmed: 1439361
Circulation. 1969 Jun;39(6):775-84
pubmed: 4239495
Pediatr Blood Cancer. 2016 Apr;63(4):743-5
pubmed: 26728130
Pediatr Hematol Oncol. 2002 Apr-May;19(3):157-61
pubmed: 11936728
Paediatr Child Health. 2005 Dec;10(10):597-601
pubmed: 19668671
Blood Transfus. 2020 Mar;18(2):106-116
pubmed: 31855149
J Pediatr. 1999 Oct;135(4):514-6
pubmed: 10518088
Can J Public Health. 2005 Jul-Aug;96(4):304-7
pubmed: 16625803